Preclinical Models for Assessment of Antidepressant Abuse Potential

Preclinical Models for Assessment of Antidepressant Abuse Potential Curr Sex Health Rep (2017) 9:241–250 https://doi.org/10.1007/s11930-017-0128-z PRECLINICAL AND PSYCHOPHYSIOLOGY (F GUARRACI AND L MARSON, SECTION EDITORS) Preclinical Models for Assessment of Antidepressant Abuse Potential 1 2 M. F. Lazenka & B. A. Hutsell Published online: 17 October 2017 Springer Science+Business Media, LLC 2017 Abstract Introduction Purpose of Review This review considers the contribution of monoamine neurotransmitters to anhedonia, substance abuse, Depression has a worldwide prevalence of approximately 2– and sexual dysfunction and the relationship between antide- 5%. However, only half of patients in treatment remain symp- pressant efficacy and abuse liability. tom free and at least 10–20% of patients meet the criteria for Recent Findings The use of drugs with known abuse potential treatment-resistant depression [1]. Furthermore, sexual dys- to treat depression, the addition of psychostimulants with an- function (including desire, arousal, orgasm, and ejaculation) tidepressants, and the development of novel antidepressants is a common comorbidity with depression [2, 3]and, unfortu- with preclinical evidence for abuse liability have increased in nately, current antidepressants can exacerbate sexual dysfunc- recent years. This is in contrast to the general lack of abuse tion [4]. Therefore, new medications are clearly necessary. potential reported for traditional antidepressants such as selec- Development of pharmacotherapies http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Sexual Health Reports Springer Journals

Preclinical Models for Assessment of Antidepressant Abuse Potential

Loading next page...
 
/lp/springer_journal/preclinical-models-for-assessment-of-antidepressant-abuse-potential-Bdyx2ZYGsU
Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer Science+Business Media, LLC
Subject
Medicine & Public Health; Urology; Endocrinology
ISSN
1548-3584
eISSN
1548-3592
D.O.I.
10.1007/s11930-017-0128-z
Publisher site
See Article on Publisher Site

Abstract

Curr Sex Health Rep (2017) 9:241–250 https://doi.org/10.1007/s11930-017-0128-z PRECLINICAL AND PSYCHOPHYSIOLOGY (F GUARRACI AND L MARSON, SECTION EDITORS) Preclinical Models for Assessment of Antidepressant Abuse Potential 1 2 M. F. Lazenka & B. A. Hutsell Published online: 17 October 2017 Springer Science+Business Media, LLC 2017 Abstract Introduction Purpose of Review This review considers the contribution of monoamine neurotransmitters to anhedonia, substance abuse, Depression has a worldwide prevalence of approximately 2– and sexual dysfunction and the relationship between antide- 5%. However, only half of patients in treatment remain symp- pressant efficacy and abuse liability. tom free and at least 10–20% of patients meet the criteria for Recent Findings The use of drugs with known abuse potential treatment-resistant depression [1]. Furthermore, sexual dys- to treat depression, the addition of psychostimulants with an- function (including desire, arousal, orgasm, and ejaculation) tidepressants, and the development of novel antidepressants is a common comorbidity with depression [2, 3]and, unfortu- with preclinical evidence for abuse liability have increased in nately, current antidepressants can exacerbate sexual dysfunc- recent years. This is in contrast to the general lack of abuse tion [4]. Therefore, new medications are clearly necessary. potential reported for traditional antidepressants such as selec- Development of pharmacotherapies

Journal

Current Sexual Health ReportsSpringer Journals

Published: Oct 17, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off